The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TITANium: An open-label, global multicenter phase 1/2 study of AZD5492, a first-in-class subcutaneous CD8-guided tri-specific T-cell engager (TCE), in patients (pts) with relapsed or refractory (r/r) B-cell malignancies.
 
Mazyar Shadman
Employment - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Fate therapeutics; Genentech; Genmab; Kite, a Gilead company; Lilly; Merck; MorphoSys; Nurix; Pharmacyclics; Regeneron
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Bristol-Myers Squibb/Celgene; Celgene (Inst); Genentech (Inst); Genmab (Inst); Merck (Inst); MustangBio (Inst); Pharmacyclics (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst); Vincerx Pharma (Inst)
 
Philip Thompson
Honoraria - Abbvie; Adaptive Biotechnologies; AstraZeneca; Janssen; Merck
Consulting or Advisory Role - Abbvie; Ascentage Pharma; AstraZeneca; BeiGene; Genentech; Genmab; Janssen; Loxo/Lilly
Research Funding - Abbvie (Inst); Adaptive Biotechnologies (Inst); Genentech (Inst); Pharmacyclics (Inst); Sana Biotechnology (Inst)
Travel, Accommodations, Expenses - Merck
 
Benjamin Heyman
Honoraria - Regeneron
Consulting or Advisory Role - AstraZeneca/MedImmune; BeiGene
Research Funding - AstraZeneca/MedImmune (Inst); Beigene (Inst); Century Therapeutics (Inst); Ipsen (Inst); Oncternal Therapeutics (Inst)
Travel, Accommodations, Expenses - Genmab
 
Martin Hutchings
Consulting or Advisory Role - Abbvie; AstraZeneca; Genmab; Johnson & Johnson/Janssen; Roche; Takeda
Research Funding - Abbvie (Inst); Arvinas (Inst); AstraZeneca (Inst); Celgene (Inst); Genmab (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
 
Leslie Lori
No Relationships to Disclose
 
Junichiro Yuda
Research Funding - Abbvie; Amgen; AstraZeneca; Brighpath Bio; Bristol-Myers Squibb/Celgene; Celeid Therapeutics; Chugai Pharma; Daiichi Sankyo; Genmab; Incyte; Janssen; Mitsubishi Tanabe; MSD; Novartis; Sanofi; Sumitomo Pharma; Takeda
 
Pier Zinzani
Consulting or Advisory Role - AstraZeneca; BeiGene; Bristol-Myers Squibb; Incyte; Janssen; Kite/Gilead; Kyowa Kirin International; MSD; Novartis; Recordati; Roche; SOBI; Takeda
Speakers' Bureau - AstraZeneca; BeiGene; BMS; Incyte; Janssen; Kite/Gilead; Kyowa Kirin International; MSD; Novartis; Recordati; Roche; SOBI; Takeda
 
Dachelle Colton
Employment - AstraZeneca/MedImmune
 
Daniela Hoehn
Employment - AstraZeneca/MedImmune; Genmab
Stock and Other Ownership Interests - AstraZeneca
 
Macarena Izuzquiza
Employment - AstraZeneca/MedImmune
 
Anthony Mato
Employment - AstraZeneca/MedImmune
 
Gullu Gorgun
Employment - AstraZeneca/MedImmune
 
Robert Chen
Honoraria - Genentech/Roche; Merck; Millennium; Seagen
Consulting or Advisory Role - Genentech/Roche; Merck; Seagen
Speakers' Bureau - Genentech/Roche; Millennium; Seagen
Research Funding - Millennium; Pharmacyclics; Seagen
Travel, Accommodations, Expenses - Genentech/Roche; Merck; Seagen
 
John Kuruvilla
Honoraria - Abbvie; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; Genmab; Gilead Sciences; Incyte; Janssen; Kite/Gilead; Merck; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - Abbvie; Arvinas; Bristol-Myers Squibb; Gilead Sciences; Merck; Roche; Seagen
Research Funding - AstraZeneca; Merck; Roche
Other Relationship - Karyopharm Therapeutics